# Treatment With AKL1 in Obstructive Airways Disease (The TAKL Study)

> **NCT00920127** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University of East Anglia** · enrollment: 164 (estimated)

## Conditions studied

- Obstructive Lung Disease
- Chronic Obstructive Pulmonary Disease
- Asthma

## Interventions

- **DIETARY_SUPPLEMENT:** AKL1

## Key facts

- **NCT ID:** NCT00920127
- **Lead sponsor:** University of East Anglia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2011-02
- **Final completion:** 2012-02
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2011-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00920127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00920127, "Treatment With AKL1 in Obstructive Airways Disease (The TAKL Study)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00920127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*